Search Results
Overview
| Uniprot ID | Q96ST3 |
|---|---|
| Protein Name | Paired amphipathic helix protein Sin3a |
| Gene Name | SIN3A |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position | Flanking peptide |
|---|---|
| 1170 | DKLECRFKLNSYKMV |
| 396 | LSKTTAEKVDSVRND |
| 439 | TGTTPPVKKKPKLLN |
| 440 | GTTPPVKKKPKLLNL |
| 443 | PPVKKKPKLLNLKDS |
| 448 | KPKLLNLKDSSMADA |
| 457 | SSMADASKHGGGTES |
| 535 | VHLETYPKERATEGI |
| 563 | SSYRALPKSYQQPKC |
| 569 | PKSYQQPKCTGRTPL |
| 602 | STFVSSKKTQYEEHI |
| 865 | GGSPPKSKLLFSNTA |
| 875 | FSNTAAQKLRGMDEV |
| 937 | VLGIKRDKSDSPAIQ |
Function
Acts as a transcriptional repressor. Corepressor for REST. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Also interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. Acts cooperatively with OGT to repress transcription in parallel with histone deacetylation. Involved in the control of the circadian rhythms. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression (By similarity). Required for cortical neuron differentiation and callosal axon elongation (By similarity)
Protein Sequence
Gene Ontology
| Classification | GO ID | Description |
|---|---|---|
| Cellular Component | GO:0000785 | chromatin |
| Cellular Component | GO:0000118 | histone deacetylase complex |
| Cellular Component | GO:0000776 | kinetochore |
| Cellular Component | GO:0005730 | nucleolus |
| Cellular Component | GO:0005654 | nucleoplasm |
| Cellular Component | GO:0005634 | nucleus |
| Cellular Component | GO:0070822 | Sin3-type complex |
| Cellular Component | GO:0017053 | transcription repressor complex |
| Molecular Function | GO:0003682 | chromatin binding |
| Molecular Function | GO:0003677 | DNA binding |
| Molecular Function | GO:0044877 | protein-containing complex binding |
| Molecular Function | GO:0003723 | RNA binding |
| Molecular Function | GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding |
| Molecular Function | GO:0003714 | transcription corepressor activity |
| Molecular Function | GO:0140416 | transcription regulator inhibitor activity |
| Biological Process | GO:0002218 | activation of innate immune response |
| Biological Process | GO:1903351 | cellular response to dopamine |
| Biological Process | GO:0072736 | cellular response to tert-butyl hydroperoxide |
| Biological Process | GO:0021895 | cerebral cortex neuron differentiation |
| Biological Process | GO:0006351 | DNA-templated transcription |
| Biological Process | GO:0031507 | heterochromatin formation |
| Biological Process | GO:0030336 | negative regulation of cell migration |
| Biological Process | GO:0042754 | negative regulation of circadian rhythm |
| Biological Process | GO:0045892 | negative regulation of DNA-templated transcription |
| Biological Process | GO:1900181 | negative regulation of protein localization to nucleus |
| Biological Process | GO:1902455 | negative regulation of stem cell population maintenance |
| Biological Process | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| Biological Process | GO:0060633 | negative regulation of transcription initiation by RNA polymerase II |
| Biological Process | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway |
| Biological Process | GO:0002230 | positive regulation of defense response to virus by host |
| Biological Process | GO:0045666 | positive regulation of neuron differentiation |
| Biological Process | GO:1902459 | positive regulation of stem cell population maintenance |
| Biological Process | GO:0030516 | regulation of axon extension |
| Biological Process | GO:0010817 | regulation of hormone levels |
| Biological Process | GO:0048511 | rhythmic process |
| Biological Process | GO:0060337 | type I interferon-mediated signaling pathway |
Reference
[1] Yang D, Yin J, Shan L, Yi X, Zhang W et al.. Identification of lysine-lactylated substrates in gastric cancer cells.. iScience 25(7):104630. 2022 Jul 15. PMID: 35800753.
[2] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.
[3] He C, Zhang J, Bai X, Lu C, Zhang K. Lysine lactylation-based insight to understanding the characterization of cervical cancer.. Biochim Biophys Acta Mol Basis Dis 1870(7):167356. 2024 Oct. PMID: 39025375.
[4] Bao Q, Wan N, He Z, Cao J, Yuan W et al.. Subcellular Proteomic Mapping of Lysine Lactylation.. J Am Soc Mass Spectrom 35(12):3221-3232. 2024 Dec 4. PMID: 39569522.
[5] Guo X, Ren X, Yan C, Huang H. Quantitative Proteomics Reveals the Role of Lysine Lactylation in Lenalidomide-Resistance in Multiple Myeloma Cells.. ACS Chem Biol 20(7):1728-1738. 2025 Jul 18. PMID: 40590393.
[6] He J, Lai T, Zhou Z, Yang H, Lei Z et al.. Multiomics profiling reveals the involvement of protein lactylation in nonhomologous end joining pathway conferring radioresistance in lung adenocarcinoma cell.. Sci Rep 15(1):24651. 2025 Jul 9. PMID: 40634431.
[7] Wu Q, Li Z, Gong T, Zheng X, Zhou X et al.. Porphyromonas gingivalis infection induces lysine lactylation reprogramming in human umbilical vein endothelial cells.. Front Cell Infect Microbiol 16:1706727. 2026. PMID: 41696360.